Exhibit A

JOINT FILING AGREEMENT

The undersigned agree that this Schedule 13G Amendment No. 4 dated February 11, 2025 relating to the Common Stock, par value $0.001 per share, of Marinus Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.

 

SUVRETTA CAPITAL MANAGEMENT, LLC

 

By: /s/ Aaron Cowen

  Name: Aaron Cowen
  Title:   Authorized Signatory

 

 

 

AVERILL MASTER FUND, LTD.

 

By: /s/ Aaron Cowen

  Name: Aaron Cowen
  Title:   Director

 

 

 

AARON COWEN

 

By: /s/ Aaron Cowen

 

 

 

 

Exhibit B

CONTROL PERSON IDENTIFICATION

Suvretta Capital Management, LLC is the relevant entity for which Aaron Cowen is the control person.

Marinus Pharmaceuticals (NASDAQ:MRNS)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Marinus Pharmaceuticals 차트를 더 보려면 여기를 클릭.
Marinus Pharmaceuticals (NASDAQ:MRNS)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Marinus Pharmaceuticals 차트를 더 보려면 여기를 클릭.